Ascentage Pharma Group International
HKEX:6855
Ascentage Pharma Group International
Revenue
Ascentage Pharma Group International
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ascentage Pharma Group International
HKEX:6855
|
Revenue
¥222m
|
CAGR 3-Years
161%
|
CAGR 5-Years
101%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Revenue
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Revenue
¥6.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
266%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Revenue
¥5.5B
|
CAGR 3-Years
33%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Revenue
¥49.7B
|
CAGR 3-Years
53%
|
CAGR 5-Years
65%
|
CAGR 10-Years
50%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Revenue
¥1.9B
|
CAGR 3-Years
51%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
See Also
What is Ascentage Pharma Group International's Revenue?
Revenue
222m
CNY
Based on the financial report for Dec 31, 2023, Ascentage Pharma Group International's Revenue amounts to 222m CNY.
What is Ascentage Pharma Group International's Revenue growth rate?
Revenue CAGR 5Y
101%
Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Ascentage Pharma Group International have been 161% over the past three years , 101% over the past five years .